Indian Tamoxifen Exporters: Complete Supplier Ranking with Market Share — 220 Manufacturers (2026) — TransData Nexus

Q: Who is the largest tamoxifen supplier from India?

EUGIA PHARMA SPECIALITIES LIMITED is the largest tamoxifen exporter from India with a 45.3% market share and export value of $6.7M.

Q: How many tamoxifen suppliers are there in India?

There are 220 active tamoxifen exporters in India, collectively shipping $14.7M worth of tamoxifen across 3,139 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top tamoxifen suppliers from India?

The top 5 tamoxifen suppliers from India — EUGIA PHARMA SPECIALITIES LIMITED, PRATAP ORGANICS PRIVATE LIMITED, GRANULES INDIA LIMITED, BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED, KHANDELWAL LABORATORIES PRIVATE LIMITED — together control 87.8% of total tamoxifen export value from India.

Suresh Sormare

Tamoxifen

India Pharmaceutical Trade Intelligence

$14.7M220 Suppliers104 CountriesHS 30049048

ExportsIndia → UNITED STATES42.5%India → GERMANY24.0%

ImportsUNITED STATES → India$2.0M GREECE → India$8.4K

#1 Supplier: EUGIA PHARMA #1 Buyer: AUROBINDO PHARMA

Tamoxifen Suppliers from India (2026) — 220 Exporters, $14.7M Market | TransData Nexus | TransData Nexus

Who Exports Tamoxifen from India — 220 Suppliers Behind a $14.7M Market

India's tamoxifen export market is supplied by 220 active exporters who collectively shipped $14.7M across 3,139 shipments. EUGIA PHARMA SPECIALITIES LIMITED leads with a 45.3% market share, followed by PRATAP ORGANICS PRIVATE LIMITED and GRANULES INDIA LIMITED. The top 5 suppliers together control 87.8% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Tamoxifen Suppliers & Exporters — 220 manufacturers, $14.7M export market, top destinations and formulations — Tamoxifen supplier data — 220 exporters · $14.7M market · 3,139 shipmentsTransData Nexus · Indian Customs Data

Top Tamoxifen Exporters from India — Ranked by Export Value

EUGIA PHARMA SPECIALITIES LIMITED is the leading tamoxifen exporter from India, holding a 45.3% share of the $14.7M market across 3,139 shipments from 220 exporters. The top 5 suppliers — EUGIA PHARMA SPECIALITIES LIMITED, PRATAP ORGANICS PRIVATE LIMITED, GRANULES INDIA LIMITED, BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED, KHANDELWAL LABORATORIES PRIVATE LIMITED — collectively control 87.8% of total export value, indicating a highly concentrated market. Individual shares are: EUGIA PHARMA SPECIALITIES LIMITED (45.3%), PRATAP ORGANICS PRIVATE LIMITED (19.1%), GRANULES INDIA LIMITED (12.7%), BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED (5.6%), KHANDELWAL LABORATORIES PRIVATE LIMITED (5.0%).

Top Tamoxifen Exporters from India

Ranked by export value · 220 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Tamoxifen Exporters from India — Ranked by Export Value. 220 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Tamoxifen exporters

Certification and compliance status for top Tamoxifen suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Eugia Pharma Specialities Limited	Warning Letter, August 20	Yes, as of December	No	Not verified	Received FDA Warning Letter in August 2024 for CGMP violations at Unit III facil
BDR Pharmaceuticals International Private Limited	Not Listed	Yes, as of November	No	Not verified	Participated in India's PLI scheme for pharmaceuticals as of November 2021.
Steril-Gene Life Sciences Private Limited	Not Listed	Yes, as of November	No	Not verified	Participated in India's PLI scheme for pharmaceuticals as of November 2021.
Wockhardt Limited	Approved	Yes, as of December	Yes	Multiple	Holds multiple FDA approvals and WHO-GMP certification.
Granules India Limited	Approved	Yes, as of December	Yes	Multiple	Holds multiple FDA approvals and WHO-GMP certification.
Caplin Point Laboratories Limited	Approved	Yes, as of December	Yes	Multiple	Holds multiple FDA approvals and WHO-GMP certification.
Neon Laboratories Limited	Not Listed	Yes, as of December	No	Not verified	Holds WHO-GMP certification.
Khandelwal Laboratories Private Limited	Not Listed	Yes, as of December	No	Not verified	Holds WHO-GMP certification.

TransData Nexus reviewed the regulatory standing of 8 leading Tamoxifen exporters from India. 3 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 3 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Tamoxifen sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as India's "Bulk Drug Capital," is renowned for its extensive production of active pharmaceutical ingredients (APIs). The city's pharmaceutical landscape is anchored by Genome Valley, a hub for R&D and biologics, and Hyderabad Pharma City, an integrated cluster under development aimed at consolidating APIs, formulations, and support services. This robust infrastructure positions Hyderabad as a pivotal player in the API sector, potentially contributing significantly to Tamoxifen production.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is a prominent formulations hub, housing major pharmaceutical companies like Zydus Lifesciences and Cadila Pharmaceuticals. These companies are engaged in the manufacturing of generic drugs and formulations, indicating a strong capacity for producing finished Tamoxifen products. The region's deep chemical supply chains and proximity to ports like Mundra and Pipavav facilitate efficient export logistics.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt serves as a critical export gateway for India's pharmaceutical industry. This region hosts numerous pharmaceutical headquarters and regulatory affairs talent, providing strategic advantages for companies aiming to export products like Tamoxifen. The proximity to major ports enhances the efficiency of international distribution channels.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Tamoxifen exporters from India

January 2026

M&A

EUGIA PHARMA SPECIALITIES LIMITED — Acquisition of Khandelwal's Non-Oncology Business

EUGIA PHARMA SPECIALITIES LIMITED, a wholly-owned subsidiary of Aurobindo Pharma Limited, acquired the non-oncology prescription formulations business of Khandelwal Laboratories Private Limited for ₹3.2 billion. IMPACT: This acquisition is expected to enhance EUGIA's product portfolio, potentially increasing its Tamoxifen export capacity.

Impact: This acquisition is expected to enhance EUGIA's product portfolio, potentially increasing its Tamoxifen export capacity.

February 2026

Regulatory

EUGIA PHARMA SPECIALITIES LIMITED — US FDA Approval for Everolimus Tablets

EUGIA PHARMA SPECIALITIES LIMITED received approval from the US FDA to manufacture and market Everolimus Tablets, expanding its oncology product offerings. IMPACT: This approval may bolster EUGIA's reputation in oncology, indirectly supporting Tamoxifen exports.

Impact: This approval may bolster EUGIA's reputation in oncology, indirectly supporting Tamoxifen exports.

February 2026

Common Questions — Tamoxifen Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which tamoxifen supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, EUGIA PHARMA SPECIALITIES LIMITED leads with 182 recorded shipments worth $6.7M. PRATAP ORGANICS PRIVATE LIMITED (7 shipments) and GRANULES INDIA LIMITED (25 shipments) are also established high-volume exporters.

Q How many tamoxifen manufacturers are there in India?

India has 220 active tamoxifen exporters with a combined export market of $14.7M across 3,139 shipments to 104 countries. The top 5 suppliers hold 87.8% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for tamoxifen from India?

Average FOB unit price: $3.83 per unit, ranging from $0.01 to $2094.02. Average shipment value: $4.7K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Tamoxifen

Tamoxifen

Who Exports Tamoxifen from India — 220 Suppliers Behind a $14.7M Market

Top Tamoxifen Exporters from India — Ranked by Export Value

Top Tamoxifen Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

EUGIA PHARMA SPECIALITIES LIMITED — Acquisition of Khandelwal's Non-Oncology Business

EUGIA PHARMA SPECIALITIES LIMITED — US FDA Approval for Everolimus Tablets

Common Questions — Tamoxifen Suppliers from India

Q Which tamoxifen supplier from India is the most reliable for bulk orders?

Q How many tamoxifen manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for tamoxifen from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

EUGIA PHARMA SPECIALITIES LIMITED — Completion of US FDA Inspection at Unit I

Analysis Methodology